Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection (Q73437160)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2003

Language	Label	Description	Also known as
English	Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection	scientific article published on 01 May 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

3

object named as

Mark Munsell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Richard E Champlin

9

object named as

Richard E Champlin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

8

object named as

Aman U Buzdar

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Filippo Montemurro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Gabriela Rondón

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Terry L Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Michele L Donato

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

James L Gajewski

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Zia U Rahman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Naoto T Ueno

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

330-340

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

[Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: results of the national protocol Pegase 04]

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of prognostic factors in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900088-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(03)00088-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766883%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73437160&oldid=2139211386"